Researchers find biomarkers for identifying Alzheimer's and mild cognitive impairment in saliva samples

December 6, 2018 by Katie Willis, University of Alberta
Roger Dixon (left) and Liang Li are working together to develop a saliva test for Alzheimer’s disease. Credit: John Ulan

The discovery of three biomarkers that detect mild cognitive impairment and Alzheimer's has the potential to lead to the development of a saliva test to diagnose the chronic neurodegenerative disease.

University of Alberta scientists Liang Li and Roger Dixon examined from three sets of patients: those with Alzheimer's, those with and those with normal cognition. Using a powerful mass spectrometer, the pair examined more than 6,000 metabolites—compounds that are part of our body's metabolic processes—to identify any changes or signatures between groups.

"We found three metabolites that can be used to differentiate between these three groups," said Li, adding that while the results show promise, the sample size was small.

"If we can use a larger set of samples, we can validate our findings and develop a saliva test of Alzheimer's disease," he explained.

A saliva test would prove useful in for its ease and non-invasive nature. It also has the potential to detect sooner, allowing for .

"So far, no disease-altering interventions for Alzheimer's disease have been successful," said Dixon. "Researchers are aiming to discover the earliest signals of the disease so that prevention protocols can be implemented."

The biomarkers could also be used to conduct efficacy testing for treatments.

"Using the biomarkers, we can also do testing to see what types of treatments are most effective in treating Alzheimer's disease—from diet to physical activity to pharmaceuticals," added Li.

The research was published in two papers. The first, "Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease," was published in the Journal of Alzheimer's Disease. The second, "Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers," was published in Frontiers in Aging Neuroscience.

Explore further: Diagnostic biomarkers in saliva show promise in recognizing early Alzheimer's disease

More information: Tao Huan et al. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease, Journal of Alzheimer's Disease (2018). DOI: 10.3233/JAD-180711

Shraddha Sapkota et al. Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers, Frontiers in Aging Neuroscience (2018). DOI: 10.3389/fnagi.2018.00296

Related Stories

Diagnostic biomarkers in saliva show promise in recognizing early Alzheimer's disease

May 18, 2017
Your spit may hold a clue to future brain health. Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify ...

New appropriate use criteria for lumbar puncture in Alzheimer's diagnosis

October 10, 2018
In preparation for more tools that detect and measure the biology associated with Alzheimer's and other dementias earlier and with more accuracy, an Alzheimer's Association-led Workgroup has published appropriate use criteria ...

Time to rethink how we diagnose Alzheimer's disease

October 3, 2018
With all the focus on Alzheimer disease in recent years as a result of the aging population, what have we learned? A symposium at The North American Menopause Society (NAMS) Annual Meeting in San Diego, October 3-6, will ...

New approach could lead to blood test to diagnose Alzheimer's in earliest stage

May 29, 2013
Blood offers promise as a way to detect Alzheimer's disease at its earliest onset, Mayo Clinic researchers say. They envision a test that would detect distinct metabolic signatures in blood plasma that are synonymous with ...

AI could predict cognitive decline leading to Alzheimer's disease in the next five years

October 4, 2018
A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer's disease.

New forecast shows 6 million with Alzheimer's disease, cognitive impairment

December 8, 2017
Using new methodology, scientists calculate that approximately 6 million American adults have Alzheimer's disease or mild cognitive impairment, which can sometimes be a precursor to the disease. The estimate, funded by the ...

Recommended for you

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Amyloid pathology transmission in lab mice and historic medical treatments

December 13, 2018
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Study links slowed brainwaves to early signs of dementia

December 13, 2018
To turn back the clock on Alzheimer's disease, many researchers are seeking ways to effectively diagnose the neurodegenerative disorder earlier.

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...

3-D printing offers helping hand to people with arthritis

December 11, 2018
Adaptive aids are expensive. Additive manufacturing, using low-cost 3-D printers, can save upwards of 94 percent for simple household items.

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.